• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Pier Paolo Pandolfi, MD, PhD

George C. Reisman Professor of Medicine, Department of Medicine, Harvard Medical School

Director, Cancer and Genetics Program, BIDMC Cancer Center, Beth Israel Deaconess Medical Center

Chief, Division of Genetics, Dept of Medicine, Beth Israel Deaconess Medical Center

Scientific Director, BIDMC Cancer Center, Beth Israel Deaconess Medical Center

Contact Info

Pier Paolo Pandolfi
Beth Israel Deaconess Medical Center
3 Blackfan Circle
Boston, MA, 02215
Mailstop: CLS 401
Phone: 617-735-2121
ppandolf@bidmc.harvard.edu

Assistant

Thomas Garvey
Assistant
Center for Life Sciences
Beth Israel Deaconess Medical Center
3 Blackfan Circle
Boston, MA, 02115
Mailstop: Rm 401
Phone: 617-735-2145
Fax: 617-735-2120
tgarvey1@bidmc.harvard.edu

DF/HCC Program Affiliation

Leukemia, Co-Leader
Prostate Cancer

DF/HCC Associations

Institutional Representative for BIDMC, Executive Committee
Member, Center Scientific Council

Research Abstract

The Pandolfi laboratory focuses on elucidating the molecular mechanisms and the genetics underlying the pathogenesis of leukemias, lymphomas and solid tumors as well as in modeling these cancers in the mouse. Dr. Pandolfi and colleagues have characterized the function of the fusion oncoproteins and the genes involved in the chromosomal translocations of acute promyelocytic leukemia (APL), as well as of major tumor suppressors such PTEN and p53 and novel proto-oncogenes such POKEMON. The elucidation of the molecular basis underlying APL pathogenesis has led to the development of novel and effective therapeutic strategies. As a result of these efforts, APL is now considered a curable disease. Novel therapeutic concepts have emerged from this work that are currently being tested in clinical trials.

Publications

View All Publications